Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2018, Article ID 4798425, 8 pages
https://doi.org/10.1155/2018/4798425
Research Article

Impact of Age on Outcomes in Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia

1Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA
2Department of Radiology, Mayo Clinic, Rochester, MN, USA
3Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
4Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA
5Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Scottsdale, AZ, USA

Correspondence should be addressed to Vivek N. Iyer; ude.oyam@keviv.reyi

Received 6 November 2017; Revised 1 December 2017; Accepted 15 January 2018; Published 11 February 2018

Academic Editor: Meral Beksac

Copyright © 2018 Vivek N. Iyer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Shovlin, A. E. Guttmacher, E. Buscarini et al., “Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome),” American Journal of Medical Genetics, vol. 91, no. 1, pp. 66-67, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Plauchu, J.-P. de Chadarevian, A. Bideau, and J.-M. Robert, “Age-related clinical profile of heredity hemorrhagic telangiectasia in an epidemiologically recruited population,” American Journal of Medical Genetics, vol. 32, no. 3, pp. 291–297, 1989. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Donaldson, T. M. McKeever, I. P. Hall, R. B. Hubbard, and A. W. Fogarty, “Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study,” Neurology, vol. 84, no. 18, pp. 1886–1893, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. W. Donaldson, T. M. McKeever, I. P. Hall, R. B. Hubbard, and A. W. Fogarty, “The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study,” Thorax, vol. 69, no. 2, pp. 161–167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Sabba, G. Pasculli, G. M. Lenato et al., “Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers,” Journal of Thrombosis and Haemostasis, vol. 5, no. 6, pp. 1149–1157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. D. Grosse, S. L. Boulet, A. M. Grant, M. M. Hulihan, and M. E. Faughnan, “The use of US health insurance data for surveillance of rare disorders: Hereditary hemorrhagic telangiectasia,” Genetics in Medicine, vol. 16, no. 1, pp. 33–39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. D. Kjeldsen, P. M. Torring, H. Nissen, and P. E. Andersen, “Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia,” Acta Neurologica Scandinavica, vol. 129, no. 3, pp. 192–197, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. A. O. Badheka, V. Singh, N. J. Patel et al., “Trends of hospitalizations in the United States from 2000 to 2012 of patients >60 years with aortic valve disease,” American Journal of Cardiology, vol. 116, no. 1, pp. 132–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Charlson, T. P. Szatrowski, J. Peterson, and J. Gold, “Validation of a combined comorbidity index,” Journal of Clinical Epidemiology, vol. 47, no. 11, pp. 1245–1251, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. M. E. M. Porteous, J. Burn, and S. J. Proctor, “Hereditary haemorrhagic telangiectasia: A clinical analysis,” Journal of Medical Genetics, vol. 29, no. 8, pp. 527–530, 1992. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Sabba, G. Pasculli, P. Suppressa et al., “Life expectancy in patients with hereditary haemorrhagic telangiectasia,” QJM: Monthly Journal of the Association of Physicians, vol. 99, no. 5, pp. 327–334, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Thenganatt, J. Schneiderman, R. H. Hyland, J. Edmeads, J. L. Mandzia, and M. E. Faughnan, “Migraines linked to intrapulmonary right-to-left shunt,” Headache, vol. 46, no. 3, pp. 439–443, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Dupuis-Girod, I. Ginon, J.-C. Saurin et al., “Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output,” The Journal of the American Medical Association, vol. 307, no. 9, pp. 948–955, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. E. Faughnan, V. A. Palda, G. Garcia-Tsao et al., “International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia,” Journal of Medical Genetics, vol. 48, no. 2, pp. 73–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Pierucci, G. M. Lenato, P. Suppressa et al., “A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study,” Orphanet Journal of Rare Diseases, vol. 7, no. 1, article 33, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Lesca, C. Olivieri, N. Burnichon et al., “Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network,” Genetics in Medicine, vol. 9, no. 1, pp. 14–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. A. D. Kjeldsen, T. R. Moller, K. Brusgaard, P. Vase, and P. E. Andersen, “Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia,” Journal of Internal Medicine, vol. 258, no. 4, pp. 349–355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. T. G. W. Letteboer, J. J. Mager, R. J. Snijder et al., “Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia,” Journal of Medical Genetics, vol. 43, no. 4, pp. 371–377, 2006. View at Publisher · View at Google Scholar · View at Scopus